-
公开(公告)号:US20230391890A1
公开(公告)日:2023-12-07
申请号:US18249187
申请日:2021-10-15
发明人: David C. LYDEN , Goncalo RODRIGUES , Irena RAJNPREHT , Abdul KHAN , Ivo LORENZ , Irina MATEI
CPC分类号: C07K16/40 , A61P35/04 , C07K2317/76 , C07K2317/92
摘要: The present disclosure relates to antibody-based molecules, including antibodies, epitope-binding domains thereof, and antibody derivative as described herein, that are capable of binding and inhibiting cell migration-inducing and hyaluronan-binding protein (CEMIP). Such antibody-based molecules are useful for the treatment of conditions where a subject is in need of blocking the activity of CEMIP.
-
公开(公告)号:US20240000959A1
公开(公告)日:2024-01-04
申请号:US18039369
申请日:2021-11-30
申请人: CORNELL UNIVERSITY
发明人: Neil H. BANDER , Wilhem LECONET , Ming GUO , He LIU , Ivo LORENZ , Abdul G. KHAN
CPC分类号: A61K47/67 , C07K16/2803 , C07K16/3069 , A61P35/00 , C12N9/1051 , C12Y204/01069 , C12Y204/01087 , C07K2317/55 , C07K2317/622 , A61K2039/505
摘要: The present application relates to a bi-functional therapeutic for treating cancer that includes a targeting component which targets a tumor-associated antigen and an enzyme which, when delivered to a tumor by said targeting component, converts the tumor phenotype to that of an incompatible allograft or xenograft. The enzyme is coupled to the targeting component. Also disclosed is a method for treating cancer comprising administering the bi-functional therapeutic.
-